Wang, J <br/><br/>
Transforming growth factor-beta in the red nucleus plays antinociceptive effect under physiological and pathological pain conditions.  [electronic resource] 

 -  Neuroscience  Apr 2015 
 - 37-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7544 
<br/><br/><label>Standard No.: </label>10.1016/j.neuroscience.2015.01.059  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics--administration & dosage<br/>Animals<br/>Antibodies--administration & dosage<br/>Astrocytes--metabolism<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Hyperalgesia--drug therapy<br/>Male<br/>Microglia--metabolism<br/>Microinjections<br/>Neuralgia--drug therapy<br/>Neurons--metabolism<br/>Oligodendroglia--metabolism<br/>Pain Threshold--drug effects<br/>Peripheral Nerve Injuries--drug therapy<br/>Protein Serine-Threonine Kinases--immunology<br/>Rats, Sprague-Dawley<br/>Receptor, Transforming Growth Factor-beta Type I<br/>Receptors, Transforming Growth Factor beta--immunology<br/>Recombinant Proteins--administration & dosage<br/>Red Nucleus--drug effects<br/>Sciatic Nerve--injuries<br/>Transforming Growth Factor beta--administration & dosage